The Hematocrit Paradox – How Does Blood Doping Really Work?

 

 Buy Article Permissions and Reprints

Abstract

The wide-spread assumption that doping with erythropoietin or blood transfusion is only effective by increasing arterial blood O2 content because of rising hematocrit is not self-evident. “Natural blood dopers” (horses, dogs) increase both hematocrit and circulating blood volume during exercise by releasing stored erythrocytes from the spleen. Improvement of aerobic performance by augmenting hemoglobin concentration may be expected until the optimal hematocrit is reached; above this value maximal cardiac output declines due to the steep increase of blood viscosity. Therefore an enlarged blood oxygen content might only be useful if the normal hematocrit of man during exercise is suboptimal. However, recent studies suggest that cardiac power rises after erythropoietin allowing an unchanged cardiac output in spite of increased viscosity. Other factors underlying improved performance after blood doping might be: augmented diffusion capacity for oxygen in lungs and tissues, increased percentage of young red cells with good functional properties (after erythropoietin), increased buffer capacity, increase of blood volume, vasoconstriction, reduced damage by radicals, mood improvement by cerebral effects of erythropoietin. Also the importance of placebo is unknown since double-blind studies are rare. It is suggested that blood doping has multifactorial effects not restricted to the increase in arterial oxygen content.

References

• 1 Altman PL, Dittmer DS. (eds) Respiration and Circulation.  Bethesda, Maryland: Federation of the American Societies for Experimental Biology. 1971; 
  CrossrefPubMedGoogle Scholar
• 2 Amin TM, Sirs JA. The blood rheology of man and various animal species.  Q J Exp Physiol. 1985;  70 37-49
  PubMedGoogle Scholar
• 3 Araki J, Shimizu J, Mikane T, Mohri S, Matsubara H, Yamaguchi H, Sano S, Ohe T, Takaki M, Suga H. Ventricular pressure-volume area (PVA) accounts for cardiac energy consumption of work production and absorption.  AdvExpMed Biol. 1998;  453 491-497
  PubMedGoogle Scholar
• 4 Ashenden MJ, Gore CJ, Parisotto R, Sharpe K, Hopkins WG, Hahn AG. Effect of altitude on second-generation blood tests to detect erythropoietin abuse by athletes.  Haematologica. 2003;  88 1053-1062
  PubMedGoogle Scholar
• 5 Beedie CJ, Foad AJ. The placebo effect in sports performance: a brief review.  Sports Med. 2009;  39 313-329
  CrossrefPubMedGoogle Scholar
• 6 Birkeland KI, Stray-Gundersen J, Hemmersbach P, Hallen J, Haug E, Bahr R. Effect of thEPO administration on serum levels of sTfR and cycling performance.  Med Sci Sport Exerc. 2000;  32 1238-1243
  CrossrefPubMedGoogle Scholar
• 7 Böning D. Altitude and hypoxia training – a short review.  Int J Sports Med. 1997;  18 565-570
  Article in Thieme ConnectPubMedGoogle Scholar
• 8 Böning D, Cristancho E, Serrato M, Reyes O, Mora M, Coy l, Rojas J. Hemoglobin mass and peak oxygen uptake in untrained and trained female altitude residents.  Int J Sports Med. 2004;  25 1-8
  Google Scholar
• 9 Böning D, Maassen N, Jochum F, Steinacker J, Halder A, Thomas A, Schmidt W, Noé G, Kubanek B. After-effects of a high altitude expedition on blood.  Int J Sports Med.. 1997;  18 179-185
  Article in Thieme ConnectPubMedGoogle Scholar
• 10 Böning D, Maassen N, Pries A. No proof for augmented arterial oxygen content as only factor influencing exercise capacity after Epo doping.  Letter to the Editor. J Appl Physiol. 2008;  105 1988
  PubMedGoogle Scholar
• 11 Böning D, Rojas J, Serrato M, Reyes O, Coy L, Mora M. Extracellular pH defense against lactic acid in untrained and trained altitude residents.  Eur J Appl Physiol. 2008;  103 127-137
  CrossrefPubMedGoogle Scholar
• 12 Brien AJ, Simon TL. The effects of red blood cell infusion on 10-km race time.  JAMA. 1987;  257 2761-2765
  CrossrefPubMedGoogle Scholar
• 13 Brun JF, Bouchahda C, Chaze D, Benhaddad AA, Micallef JP, Mercier J. The paradox of hematocrit in exercise physiology: which is the ”normal” range from an hemorheologist's viewpoint?.  Clin Hemorheol Microcirc. 2000;  22 287-303
  PubMedGoogle Scholar
• 14 Buick FJ, Gledhill N, Froese AB, Spriet L, Meyers EC. Effect of induced erythrocythemia on aerobic work capacity.  J Appl Physiol. 1980;  48 636-642
  PubMedGoogle Scholar
• 15 Calbet JA, Lundby C, Koskolou M, Boushel R. Importance of hemoglobin concentration to exercise: acute manipulations.  Respir Physiol Neurobiol. 2006;  151 132-140
  CrossrefPubMedGoogle Scholar
• 16 Cayla JL, Maire P, Duvallet A, Wahrmann JP. Erythropoietin induces a shift of muscle phenotype from fast glycolytic to slow oxidative.  Int J Sports Med. 2008;  29 460-465
  Article in Thieme ConnectPubMedGoogle Scholar
• 17 Chattopadhyay A, Choudhury TD, Bandyopadhyay D, Datta AG. Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical.  Biochem Pharmacol. 2000;  59 419-425
  CrossrefPubMedGoogle Scholar
• 18 Crawford JH, Isbell TS, Huang Z, Shiva S, Chacko BK, Schechter AN, Darley-Usmar VM, Kerby JD, Lang Jr JD, Kraus D, Ho C, Gladwin MT, Patel RP. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation.  Blood. 2006;  107 566-574
  CrossrefPubMedGoogle Scholar
• 19 Crowell JW, Smith EE. Determination of the optimal hematocrit.  J Appl Physiol. 1967;  22 501-504
  PubMedGoogle Scholar
• 20 Dempsey JA, Wagner PD. Exercise-induced arterial hypoxemia.  J Appl Physiol. 1999;  87 1997-2006
  PubMedGoogle Scholar
• 21 Ekblom B. Counterpoint: maximal oxygen uptake is not limited by a central nervous system governor.  J Appl Physiol. 2009;  106 339-341
  CrossrefPubMedGoogle Scholar
• 22 Ekblom B. Blood boosting and sport.  Balliere's Clin Endocrinol Metab. 2000;  14 89-98
  PubMedGoogle Scholar
• 23 Ekblom B, Wilson G, Astrand PO. Central circulation during exercise after venesection and reinfusion of red blood cells.  J Appl Physiol. 1976;  40 379-383
  PubMedGoogle Scholar
• 24 El-Sayed MS, Ali N, El-Sayed AZ. Haemorheology in exercise and training.  Sports Med. 2005;  35 649-670
  CrossrefPubMedGoogle Scholar
• 25 Gaehtgens P, Kreutz F, Albrecht KH. Optimal hematocrit for canine skeletal muscle during rhythmic isotonic exercise.  Eur J Appl Physiol. 1979;  41 27-39
  CrossrefPubMedGoogle Scholar
• 26 Gore CJ, Clark SA, Saunders PU. Nonhematological mechanisms of improved sea-level performance after hypoxic exposure.  Med Sci Sports Exerc. 2007;  39 1600-1609
  PubMedGoogle Scholar
• 27 Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, Mildner-Rihm C, Martin H, Zeiher AM, Dimmeler S. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization.  Blood. 2003;  102 1340-1346
  CrossrefPubMedGoogle Scholar
• 28 Heidenreich S, Rahn KH, Zidek W. Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels.  Kidney Int. 1991;  39 259-265
  CrossrefPubMedGoogle Scholar
• 29 Heinicke K, Wolfarth B, Winchenbach P, Biermann B, Schmid A, Huber G, Friedmann B, Schmidt W. Blood volume and hemoglobin mass in elite athletes of different disciplines.  Int J Sports Med. 2001;  22 504-512
  Article in Thieme ConnectPubMedGoogle Scholar
• 30 Hsia CC, Johnson Jr RL, Dane DM, Wu EY, Estrera AS, Wagner HE, Wagner PD. The canine spleen in oxygen transport: gas exchange and hemodynamic responses to splenectomy.  J Appl Physiol. 2007;  103 1496-1505
  CrossrefPubMedGoogle Scholar
• 31 Kuipers H, Moran J, Dubravcic-Simunjak S, Mitchell DW, Shobe J, Sakai H, Ambartsumov R. Hemoglobin level in elite speed skaters from 2000 up to 2005, and its relationship with competitive results.  Int J Sports Med. 2007;  28 16-20
  Article in Thieme ConnectPubMedGoogle Scholar
• 32 Levine BD. V˙O₂ max: what do we know, and what do we still need to know?.  J Physiol. 2008;  586 25-34
  CrossrefPubMedGoogle Scholar
• 33 Lundby C, Robach P, Boushel R, Thomsen JJ, Rasmussen P, Koskolou M, Calbet JA. Does recombinant human Epo increase exercise capacity by means other than augmenting oxygen transport?.  J Appl Physiol. 2008;  105 581-587
  CrossrefPubMedGoogle Scholar
• 34 Lundby C, Thomsen JJ, Boushel R, Koskolou M, Warberg J, Calbet JA, Robach P. Erythropoietin treatment elevates haemoglobin concentration by increasing red cell volume and depressing plasma volume.  J Physiol. 2007;  578 309-314
  CrossrefPubMedGoogle Scholar
• 35 Miskowiak K, Inkster B, Selvaraj S, Wise R, Goodwin GM, Harmer CJ. Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration.  Neuropsychopharmacology. 2008;  33 611-618
  CrossrefPubMedGoogle Scholar
• 36 Morkeberg JS, Belhage B, Damsgaard R. Changes in blood values in elite cyclists.  Int J Sports Med. 2009;  30 130-138
  Article in Thieme ConnectPubMedGoogle Scholar
• 37 Pries AR, Secomb TW, Sperandio M, Gaehtgens P. Blood flow resistance during hemodilution: effect of plasma composition.  Cardiovasc Res. 1998;  37 225-235
  CrossrefPubMedGoogle Scholar
• 38 Prommer N, Ehrmann U, Schmidt W, Steinacker JM, Radermacher P, Muth CM. Total haemoglobin mass and spleen contraction: a study on competitive apnea divers, non-diving athletes and untrained control subjects.  Eur J Appl Physiol. 2007;  101 753-759
  CrossrefPubMedGoogle Scholar
• 39 Prommer N, Heckel A, Schmidt W. Timeframe to detect blood withdrawal associated with autologous blood doping.  Med Sci Sports Exerc. 2007;  39 S3
  PubMedGoogle Scholar
• 40 Prommer N, Thoma S, Quecke L, Gutekunst T, Völzke C, Wachsmuth N, Niess A, Schmidt W. Total hemoglobin mass, blood volume and heart dimensions in elite Kenyan runners.  Med Sci Sport Exerc. 2010;  42 791-797
  PubMedGoogle Scholar
• 41 Rentsch RL, Damsgaard R, Lundby C, Juel C. Effects of darbepoetin injections on erythrocyte membrane transport protein expressions in humans.  J Appl Physiol. 2006;  101 164-168
  CrossrefPubMedGoogle Scholar
• 42 Robertson HT, Haley NR, Guthrie M, Cardenas D, Eschbach JW, Adamson JW. Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients.  Am J Kidney Dis. 1990;  15 325-332
  PubMedGoogle Scholar
• 43 Robertson RJ, Gilcher R, Metz KF, Caspersen CJ, Allison TG, Abbott RA, Skrinar GS, Krause JR. Hemoglobin concentration and aerobic work capacity in women following induced erythrocytemia.  J Appl Physiol. 1984;  57 568-575
  PubMedGoogle Scholar
• 44 Robertson RJ, Gilcher R, Metz KF, Skrinar GS, Allison TG, Bahnson HT, Abbott R, Becker R. Effect of induced erythrocythemia on hypoxia tolerance during physical exercise.  J Appl Physiol. 1982;  53 490-495
  PubMedGoogle Scholar
• 45 Robinson Y, Cristancho E, Böning D. Erythrocyte aspartate aminotransferase activity as a possible indirect marker for stimulated erythropoiesis in male and female athletes.  Lab Hematol. 2007;  13 49-55
  CrossrefPubMedGoogle Scholar
• 46 Rotter R, Menshykova M, Winkler T, Matziolis G, Stratos I, Schoen M, Bittorf T, Mittlmeier T, Vollmar B. Erythropoietin improves functional and histological recovery of traumatized skeletal muscle tissue.  J Orthop Res. 2008;  26 1618-1626
  CrossrefPubMedGoogle Scholar
• 47 Sawka MN, Convertino VA, Eichner ER, Schnieder SM, Young AJ. Blood volume: importance and adaptations to exercise training, environmental stresses, and trauma/sickness.  Med Sci Sports Exerc. 2000;  32 332-348
  CrossrefPubMedGoogle Scholar
• 48 Sawka MN, Joyner MJ, Miles DS, Robertson RJ, Spriet LL, Young AJ. American College of Sports Medicine Position Stand. The use of blood doping as an ergogenic aid.  Med Sci Sport Exerc. 1996;  28 i-viii
  CrossrefPubMedGoogle Scholar
• 49 Schaffartzik W, Barton ED, Poole DC, Tsukimoto K, Hogan MC, Bebout DE, Wagner PD. Effect of reduced hemoglobin concentration on leg oxygen uptake during maximal exercise in humans.  J Appl Physiol. 1993;  75 491-498
  PubMedGoogle Scholar
• 50 Schmidt W, Böning D, Braumann KM. Red cell age effects on metabolism and oxygen affinity in humans.  Respir Physiol. 1987;  68 215-225
  CrossrefPubMedGoogle Scholar
• 51 Schmidt W, Maassen N, Tegtbur U, Braumann KM. Changes in plasma volume and red cell formation after a marathon competition.  Eur J Appl Physiol. 1989;  58 453-458
  CrossrefPubMedGoogle Scholar
• 52 Schmidt W, Maassen N, Trost F, Böning D. Training induced effects on blood volume, erythrocyte turnover and haemoglobin oxygen binding properties.  Eur J Appl Physiol. 1988;  57 490-498
  CrossrefPubMedGoogle Scholar
• 53 Schmidt W, Prommer N. Effects of various training modalities on blood volume.  Scand J Med Sci Sports. 2008;  18 (S 01) 57-69
  CrossrefPubMedGoogle Scholar
• 54 Schuler B, Arras M, Keller S, Rettich A, Lundby C, Vogel J, Gassmann M. Optimal hematocrit for maximal exercise performance in acute and chronic erythropoietin-treated mice.  Proc Natl Acad Sci USA. 2010;  107 419-423
  CrossrefPubMedGoogle Scholar
• 55 Schumacher YO, Pottgiesser T, Ahlgrim C, Ruthardt S, Dickhuth HH, Roecker K. Haemoglobin mass in cyclists during stage racing.  Int J Sports Med. 2008;  29 372-378
  Article in Thieme ConnectPubMedGoogle Scholar
• 56 Singel DJ, Stamler JS. Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin.  Annu Rev Physiol. 2005;  67 99-145
  CrossrefPubMedGoogle Scholar
• 57 Spriet LL, Gledhill N, Froese AB, Wilkes DL. Effect of graded erythrocythemia on cardiovascular and metabolic responses to exercise.  J Appl Physiol. 1986;  61 1942-1948
  PubMedGoogle Scholar
• 58 Thomsen JJ, Rentsch RL, Robach P, Calbet JA, Boushel R, Rasmussen P, Juel C, Lundby C. Prolonged administration of recombinant human erythropoietin increases submaximal performance more than maximal aerobic capacity.  Eur J Appl Physiol. 2007;  101 481-486
  CrossrefPubMedGoogle Scholar
• 59 Valeri CR, Cooper AG, Pivacek LE. Limitations of measuring blood volume with iodinated I 125 serum albumin.  Arch Int Med. 1973;  132 534-538
  CrossrefPubMedGoogle Scholar
• 60 Vogel J, Kiessling I, Heinicke K, Stallmach T, Ossent P, Vogel O, Aulmann M, Frietsch T, Schmid-Schonbein H, Kuschinsky W, Gassmann M. Transgenic mice overexpressing erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity.  Blood. 2003;  102 2278-2284
  CrossrefPubMedGoogle Scholar
• 61 Wagner PD. A theoretical analysis of factors determining V˙O₂ max at sea level and altitude.  Respir Physiol. 1996;  106 329-349
  CrossrefPubMedGoogle Scholar
• 62 Warburton DE, Gledhill N, Quinney HA. Blood volume, aerobic power, and endurance performance: potential ergogenic effect of volume loading.  Clin J Sport Med. 2000;  10 59-66
  CrossrefPubMedGoogle Scholar
• 63 Wilkerson DP, Rittweger J, Berger NJ, Naish PF, Jones AM. Influence of recombinant human erythropoietin treatment on pulmonary O₂ uptake kinetics during exercise in humans.  J Physiol. 2005;  568 639-652
  CrossrefPubMedGoogle Scholar
• 64 Williams MH, Wesseldine S, Somma T, Schuster R. The effect of induced erythrocythemia upon 5-mile treadmill run time.  Med Sci Sports Exerc. 1981;  13 169-175
  PubMedGoogle Scholar
• 65 Wu EY, Ramanathan M, Hsia CCW. Role of hematocrit in the recruitment of pulmonary diffusing capacity: comparison of human and dog.  J Appl Physiol. 1996;  80 1014-1020
  PubMedGoogle Scholar

Correspondence

Prof. Dieter Böning

Charité-Universitätsmedizin

Berlin

Sportmedizin

Garystr. 5-7

14195 Berlin

Germany

Phone: +49/30/7150376

Fax: +49/30/71522918

Email: dieter.boening@charite.de